NorthEast BioLab Logo | Advanced Bioanalytical Services Lab Agile Bioanalytical Services CRO
  • Expertise
    • Menu IconAll Expertise
    • Menu IconMass Spectrometry (LC-MS)
      • Menu IconMass Spectrometry Services
      • Menu IconHPLC Testing Services
    • Menu IconMeso Scale Discovery Assay
    • Menu IconELISA Assay
      • Menu IconLuminex Multiplex Assay
    • Menu IconFlow Cytometry
    • Menu IconqPCR Analysis, ddPCR Assay
    • Menu IconWestern Blot, In Cell Western
  • Services
    • Menu IconAll Services
    • Menu IconPharmacokinetics (PK) Study
      • Menu IconToxicology (Tox) Study
      • Menu IconDose Formulation Analysis
      • Menu IconPK PD Analysis
      • Menu IconDrug Metabolism and Pharmacokinetics (DMPK)
      • Menu IconADME Studies
      • Menu IconBioequivalence and Bioavailability Studies
    • Menu IconADA Assay, Neutralizing Antibody Assay
    • Menu IconMultiplex Cytokine Assay
    • Menu IconBiomarker Assay
      • Menu IconBiomarker Assay List
    • Menu IconCell-Based Assay
      • Menu IconMechanism of Action (MOA) Studies
      • Menu IconCytotoxicity Assay
      • Menu IconBiochemical Assay
    • Menu IconBioanalytical Assay Validation
  • Solutions
    • Menu IconAll Solutions
    • Menu IconClinical CRO
      • Menu IconCentral Lab Services
      • Menu IconPBMC Services
    • Menu IconGLP Laboratory
      • Menu IconBioanalysis
      • Menu IconNon-GLP Testing
    • Menu IconPreclinical CRO
    • Menu IconMethod Development, Validation, And Transfer
      • Menu IconMethod Validation
      • Menu IconMethod Development
      • Menu IconMethod Transfer
    • Menu IconAnalytical Testing
      • Menu IconDiscovery Screening Services
      • Menu IconAnalytical Quantitation
      • Menu IconCosmetic Testing
  • About Us
    • Menu IconAbout Us
    • Menu IconOverview
    • Menu IconLeadership
    • Menu IconFacility and Equipment
    • Menu IconQuality and Compliance
    • Menu IconTherapeutic Areas
    • Menu IconWhy Us?
    • Menu IconValues
    • Menu IconProcess
    • Menu IconPartners
    • Menu IconCareers
      • Business Development Associate
      • Sr. Scientist – Cell Based Assay
      • GLP Quality Assurance Manager
      • Sr. Scientist, ELISA Immunoassay Bioanalysis
      • Sr. Scientist, LC-MS/MS Bioanalysis
      • Associate Scientist, Central Laboratory Services
      • Sr. Scientist - Pharmacokinetics (PK)
      • Content Manager, Scientific and Regulatory Writing
  • Resources
    • Menu IconLearning Center
    • Menu IconBlog
    • Menu IconCase Study
    • Menu IconVideo Brochures
    • Menu IconNews and Events
    • Menu IconTestimonials
    • Menu IconContact Us
  • Request Quote
NorthEast BioLab Logo | Advanced Bioanalytical Services Lab Agile Bioanalytical Services CRO Request Quote

Expertise

  • Menu IconAll Expertise
    • Menu IconMass Spectrometry (LC-MS)
      • Menu IconMass Spectrometry Services
      • Menu IconHPLC Testing Services
    • Menu IconMeso Scale Discovery Assay
      • Menu IconELISA Assay
        • Menu IconLuminex Multiplex Assay
      • Menu IconFlow Cytometry
        • Menu IconqPCR Analysis, ddPCR Assay
          • Menu IconWestern Blot, In Cell Western

            Services

            • Menu IconAll Services
              • Menu IconPharmacokinetics (PK) Study
                • Menu IconToxicology (Tox) Study
                • Menu IconDose Formulation Analysis
                • Menu IconPK PD Analysis
                • Menu IconDrug Metabolism and Pharmacokinetics (DMPK)
                • Menu IconADME Studies
                • Menu IconBioequivalence and Bioavailability Studies
              • Menu IconADA Assay, Neutralizing Antibody Assay
                • Menu IconMultiplex Cytokine Assay
                  • Menu IconBiomarker Assay
                    • Menu IconBiomarker Assay List
                  • Menu IconCell-Based Assay
                    • Menu IconMechanism of Action (MOA) Studies
                    • Menu IconCytotoxicity Assay
                    • Menu IconBiochemical Assay
                  • Menu IconBioanalytical Assay Validation

                    Solutions

                    • Menu IconAll Solutions
                      • Menu IconClinical CRO
                        • Menu IconCentral Lab Services
                        • Menu IconPBMC Services
                      • Menu IconGLP Laboratory
                        • Menu IconBioanalysis
                        • Menu IconNon-GLP Testing
                      • Menu IconPreclinical CRO
                        • Menu IconMethod Development, Validation, And Transfer
                          • Menu IconMethod Validation
                          • Menu IconMethod Development
                          • Menu IconMethod Transfer
                        • Menu IconAnalytical Testing
                          • Menu IconDiscovery Screening Services
                          • Menu IconAnalytical Quantitation
                          • Menu IconCosmetic Testing

                        About Us

                        • Menu IconAbout Us
                          • Menu IconOverview
                            • Menu IconLeadership
                              • Menu IconFacility and Equipment
                                • Menu IconQuality and Compliance
                                  • Menu IconTherapeutic Areas
                                    • Menu IconWhy Us?
                                      • Menu IconValues
                                        • Menu IconProcess
                                          • Menu IconPartners
                                            • Menu IconCareers
                                              • Menu IconBusiness Development Associate
                                              • Menu IconSr. Scientist – Cell Based Assay
                                              • Menu IconGLP Quality Assurance Manager
                                              • Menu IconSr. Scientist, ELISA Immunoassay Bioanalysis
                                              • Menu IconSr. Scientist, LC-MS/MS Bioanalysis
                                              • Menu IconAssociate Scientist, Central Laboratory Services
                                              • Menu IconSr. Scientist - Pharmacokinetics (PK)
                                              • Menu IconContent Manager, Scientific and Regulatory Writing

                                            Resources

                                            • Menu IconLearning Center
                                              • Menu IconBlog
                                                • Menu IconCase Study
                                                  • Menu IconVideo Brochures
                                                    • Menu IconNews and Events
                                                      • Menu IconTestimonials
                                                        • Menu IconContact Us

                                                          Request Quote

                                                            Contact Us

                                                            • Home
                                                            • MAb Bioanalysis, Monoclonal Antibody Fragment, MAb Bioanalytical Testing

                                                            Humanized Monoclonal Antibody (MAb) PK ELISA Development, GLP Validation, And MAb Bioanalysis

                                                            Abhay Pandey | NorthEast BioLab
                                                            By Abhay Pandey, MBA
                                                            Reading Time: 4 minutes
                                                            MAb Antibody

                                                            Challenge

                                                            A biotech sponsor approached us for the development and GLP validation of a PK ELISA specific to their MAb antibody bioanalysis needs. They aimed to quantify a humanized mAb fragment (FAb) targeting a growth factor implicated in a prevalent age-related degenerative disease. The process of MAb ELISA development entails several critical considerations to ensure robust bioanalytical outcomes.
                                                            Humanized MAb fragments offer distinct advantages over whole antibodies, including lower production costs, enhanced tissue penetration, and minimized risk of triggering unintended immune responses. However, these fragments pose unique challenges for immunoassay design due to the absence of domains like the Fc region, which are commonly utilized for binding and detection in immunoassays. This can affect the sensitivity of MAb ELISAs, as the binding capacity of each fragment is reduced. Despite these challenges, precise MAb PK profiling is vital for delineating the drug’s pharmacological profile.

                                                            To navigate these complexities, meticulous planning of critical reagents, alongside strategic MAb ELISA development and GLP validation, is essential. While optimizing reagent concentrations could potentially enhance assay sensitivity, it also risks amplifying background noise from both specific and nonspecific interactions among assay components, such as the therapeutic molecule, blocking agents, and coating antigen. This is particularly problematic when the assay matrix is derived from a species closely related to humans, like non-human primates, due to the possibility of cross-reactivity.

                                                            The development and validation of MAb immunoassays, therefore, demand careful attention to the unique characteristics of MAb fragments, fine-tuning of assay elements for heightened sensitivity and specificity, and the mitigation of cross-reactivity risks.

                                                            With the right MAb ELISA approach, the detection and quantification of monoclonal antibodies across diverse samples can be significantly improved. Conducting comprehensive MAb PK studies is indispensable for understanding the in vivo distribution and behavior of these antibodies. Through diligent MAb development and bioanalysis, we can achieve the assay performance necessary to fulfill the sponsor’s requirements for assessing the therapeutic impact of the MAb fragment. This holistic strategy is pivotal in propelling MAb therapeutics forward, ensuring their clinical efficacy and safety.

                                                            MAb Antibody - Standard Curves

                                                            Solution

                                                            Our team leveraged decades of collective experience in immunoassay development and troubleshooting to explore various assay configurations for MAb development. We concentrated on refining the assay for a humanized MAb to ensure precise detection and analysis.

                                                            We determined that a robust and reproducible indirect ELISA was the best approach for assaying this therapeutic. This setup involved using the antigen target of the monoclonal antibody fragment for capture and a secondary antibody against the MAb’s Fab fragment for detection. Despite its effectiveness, we faced challenges with increased background noise due to detecting only a portion of the MAb antibody.

                                                            To address this, we employed a checkerboard approach to find the optimal concentrations for coating and detection antibodies. Our veteran team also refined several aspects of the initial immunoassay, introducing a novel method that involved preincubating the detection antibody with a small percentage of a homologous matrix. This innovation significantly improved the immunoassay’s signal-to-noise ratio and sensitivity, enhancing both GLP validation and sample analysis for MAb bioanalysis.

                                                            The optimized assay enabled accurate pharmacokinetic (PK) profiling, which is crucial for understanding MAb PK behavior. Our rigorous MAb bioanalysis protocols ensured precise assessment of the MAb therapeutics’ efficacy and safety profiles. Through meticulous optimization and validation, we secured reliable data essential for advancing the MAb development of this important humanized MAb therapeutic.

                                                            FDA authorization

                                                            Outcome

                                                            An immunoassay meeting the sponsor-mandated sensitivity and specificity requirements was successfully developed and validated according to FDA bioanalytical guidelines. The bioanalysis of MAb antibody was completed in plasma and ocular fluid matrices for the GLP pharmacokinetic (PK) study in non-human primates (NHPs). Additionally, the MAb ELISA method was employed to ensure precise quantification and validation in these matrices.

                                                            Over the past decade, MAb antibody, well-known for its use in immunodetection-based assays, has also emerged as therapeutic agent for treating various diseases. Humanized MAbs, in particular, have gained prominence due to their reduced immunogenicity and improved efficacy in human patients. To provide differentiated therapeutic advantages or overcome side effects, researchers are increasingly developing modified MAb antibody fragments and seeking FDA authorization. Incorporating MAb PK studies is critical in these evaluations, as they provide detailed pharmacokinetic profiles essential for regulatory submissions. Thus, novel approaches to assay these MAb therapeutics, building on traditional immunoassay methods, are highly valuable for facilitating regulatory approval.

                                                            Advancements in MAb development and bioanalysis streamline the approval process and ensure the safety and efficacy of new treatments, significantly contributing to healthcare progress. Techniques such as MAb ELISA and MAb PK studies are crucial for accurately assessing therapeutic efficacy and safety profiles. By employing state-of-the-art methodologies, researchers gain deeper insights into the pharmacokinetics and pharmacodynamics of monoclonal antibody fragments, leading to more informed clinical decisions and regulatory submissions. Furthermore, robust MAb bioanalysis supports the exploration of novel MAb therapeutic modalities and optimization of treatment strategies, ultimately benefiting patients and advancing the field of medicine.

                                                            Registered And Inspected By Various Regulatory Agencies

                                                            • Good Laboratory Practice for Nonclinical Laboratory Studies
                                                            • Food and Drug Administration (FDA)
                                                            • Clinical Laboratory Improvement Amendments | NorthEast BioLab
                                                            • International Orgaization for Standardization |NorthEast BioLab
                                                            • DEA
                                                            • DOCP

                                                            Speak To Our Scientist About Your Monoclonal Antibody Fragment PK ELISA Immunoassay Development, GLP Validation, and MAb Bioanalysis

                                                            SPEAK TO OUR SCIENTISTS

                                                            Similar Case Study Articles

                                                            • Inflammatory Biomarker Multiplex

                                                              Multiplex Cytokine Assay, GLP Cytokine Validation, Cytokine Quantification On MSD

                                                            • Oligonucleotide Hybridization ELISA PK Assay, GLP Validation, Sample Analysis

                                                            • TaqMan Gene Expression Assay, Copy Number Variation

                                                            • Genomic Variation Analysis – TaqMan Single Nucleotide Polymorphism (SNP) Analysis

                                                            • LC MS Bioanalysis Of Oligos Using Mass Spec And Ion Pair Chromatography

                                                            • Dosing THC Lab, Cannabis Testing Lab, CBD Melatonin Testing

                                                            • HPLC-UV Method Development: Testing 9 Articles in Formulation

                                                            • Payload Plus Peptide LC MS Analysis, GLP Validation In Rat, NHP, Human Plasma

                                                            • Epigallocatechin gallate (EGCG) LC MS Analysis In VcEDTA Human Serum

                                                            • LC MS Method For Proline Amino Acid, Hydroxyproline In Mouse Tissues

                                                            • LC MS Method For DNA Adducts Analysis In Cell-Based In-Vitro Samples

                                                            • LC MS Method for Everolimus Eluting Coronary Stent Drug Delivery Systems

                                                            • Mass Spectrometry Amino Acids, Quantitative LC MS Amino Acid Analysis

                                                            • LC MS Method Development And GLP Validation For PK Plasma Sample Analysis

                                                            • Incurred Sample Reanalysis (ISR) Test, FDA Requirements, And Study Evaluation

                                                            • DBS Test

                                                              Dried Blood Spot (DBS) Sampling, DBS Collection, And DBS Analysis

                                                            Explore Our Expertise

                                                            • Mass Spectrometry (LC-MS)

                                                            • Meso Scale Discovery Assay

                                                            • ELISA Assay

                                                            • Flow Cytometry

                                                            • qPCR Analysis, ddPCR Assay

                                                            • Western Blot, In Cell Western

                                                            Contact A Scientist With Your Bioanalytical Study Details

                                                            We Will Respond Within 1 Business Day

                                                            Expertise

                                                            Expertise

                                                            • Mass Spectrometry (LC-MS)
                                                            • Meso Scale Discovery Assay
                                                            • ELISA Assay
                                                            • Flow Cytometry
                                                            • qPCR Analysis, ddPCR Assay
                                                            • Western Blot, In Cell Western

                                                            Services

                                                            Services

                                                            • Pharmacokinetics (PK) Study
                                                            • ADA Assay, Neutralizing Antibody Assay
                                                            • Multiplex Cytokine Assay
                                                            • Biomarker Assay
                                                            • Cell-Based Assay
                                                            • Bioanalytical Assay Validation

                                                            Solutions

                                                            Solutions

                                                            • Clinical CRO
                                                            • GLP Laboratory
                                                            • Preclinical CRO
                                                            • Method Development, Validation, And Transfer
                                                            • Analytical Testing

                                                            About Us

                                                            About Us

                                                            • Overview
                                                            • Leadership
                                                            • Facility and Equipment
                                                            • Quality and Compliance
                                                            • Therapeutic Areas
                                                            • Why Us?
                                                            • Values
                                                            • Process
                                                            • Partners
                                                            • Careers

                                                            Resources

                                                            Resources

                                                            • Learning Center
                                                            • Blog
                                                            • Case Study
                                                            • Video Brochures
                                                            • News and Events
                                                            • Testimonials
                                                            • Contact Us
                                                            NorthEast BioLab Logo Agile Bioanalytical Services CRO
                                                            sales@nebiolab.comFollow Up On Email
                                                            (203) 361 3780Follow Up On Phone

                                                            35 Worth Ave, Hamden, CT 06518

                                                            • Good Laboratory Practice for Nonclinical Laboratory Studies | NorthEast BioLab
                                                            • Food and Drug Administration (FDA | NorthEast BioLab
                                                            • clia
                                                            • United States Drug Enforcement Administration | NorthEast BioLab
                                                            • Department of Consumer Protection | NorthEast BioLab
                                                            • Privacy Policy
                                                            • Terms of Use
                                                            • Sitemap
                                                            All rights reserved.